Extracapillary glomerulonephritis associated with D-penicillamine;Glomerulonephrites extracapillaires secondaires a la D-penicillamine. A propos d'une observation et revue de la litterature

Nephrologie

Volumn 19, Issue 1, 1998, Pages 25-32

  Marchand Courville, S ^a   Dhib, M ^a   Fillastre, J P ^a   Godin, M ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Antineutrophil cytoplasmic antibodies; D Penicillamine; Extracapillary glomerulonephritis; Microscopic polyangiitis; Systemic sclerosis

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; PENICILLAMINE; AUTOANTIBODY; PEROXIDASE;

ADULT; ARTICLE; CASE REPORT; DIALYSIS; FEMALE; GLOMERULONEPHRITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; PLASMAPHERESIS; SYSTEMIC SCLEROSIS; BLOOD; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; REVIEW;

ADRENAL CORTEX HORMONES; AUTOANTIBODIES; CYCLOPHOSPHAMIDE; FEMALE; GLOMERULONEPHRITIS; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PENICILLAMINE; PEROXIDASE;

EID: 0031637677     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Bacon PA, Tribe CR, Mackenzie JC, Verrier Jones J, Cumming RH, Amer B. Penicillamine nephropathy in rheumatoid arthritis, Q J Med 1976; 180 : 661-84.
2. Camus JP, Crouzet J, Prier A, Leca AP. Complications du traitement de la polyarthrite rhumatoïde par la D-pénicillamine. Thérapie 1976; 31: 385-97.
3. Camus JP, Homberg JC, Crouzet J, Mery C, Delrieu F, Massias P, Abuaf N. Autoantibody formation in D-Penicillamine-treated rheumatoid arthritis. J Rheumatol 1981 ; 8 (Suppl. 7) : 80S-3S.
4. Weiss A, Markenson JA, Weiss MS, Kammerer WH. Toxicity of D-Penicillamine in rheumatoid arthritis. Am J Med 1978; 64 : 114-20.
5. Caudwell V, Jacquot C, Daugas E, Boudjeltia S, Bertocchi M, Nochy D, Bariety J. Minimal change nephropathy (MCN) with the nephrotic syndrome in patients treated with D-Penicillamine (DP) or Thiopronine (TP). XXXII Congress of the European Renal Association, 1995; 78.
6. Dische F E, Swinson DR, Hamilton EBD, Parsons V. Immunopathology of Penicillamine-induced glomerular disease. J Rheumatol 1984; 11: 584-5.
7. Hall CL, Jawad S, Harrison PR, MacKenzie JC, Bacon PA, Klouda PT, Maclver AG. Natural course of Penicillamine nephropathy : A long term study of 33 patients. BMJ 1988; 296 : 1083-6.
8. Jaffe IA, Treser G, Suzuki Y, Ehrenreich T. Nephropathy induced by D-Penicillamine. Ann intern Med 1968; 69 : 549-56.
9. Gaskin G, Thompson EM, Pusey CD. Goodpasture-like syndrome associated with anti-myeloperoxidase antibodies following penicillamine treatment. Nephrol Dial Transplant 1995; 10 : 1925-8.
10. Jones BF, Major GA. Crescentic glomerulonephritis in a patient taking penicillamine associated with antineutrophil cytoplasmic antibody. Clin Nephrol 1992; 38 : 293.
11. Lauque D, Courtin JP, Fournie B, Oksman F, Pourrat J, Carles R Syndrome pneumo-rénal induit par la D-pénicillamine : syndrome de Goodpasture ou polyartérite microscopique ? Rev Med Interne 1990; 2 : 168-71.
12. Pusey CD, Gaskin G. Disease associations with anti-neutrophil cytoplasmic antibodies. In : ANCA-Associated Vasculitides : Immunological and clinical aspects. Edited by WL Gross. New York : Plenum Press, 1993; 145-55.
13. Mathieson PW, Peat DS, Short A, Watts RA. Coexistent membranous nephropathy and ANCA-positive crescentic glomerulonephritis in association with penicillamine. Nephrol Dial Transplant 1996 ; 11 : 863-6.
14. Crawhall JC. Proteinuria in D-Penicillamine-treated rheumatoid arthritis. J Rheumatol 1981 ; 8 (Suppl. 7) : 161S-3S.
15. Dixon A, Davies J, Dormandy TL, Hamilton EBD, Holt PJL, Mason RM, Thompson M, Weber JCP, Zutshi DW. Synthetic D-Penicillamine in rheumatoid arthritis. Ann Rheum Dis 1975; 34 : 416-21.
16. Ross JH, McGinty F, Brewer DG. Penicillamine nephropathy. Nephron 1980; 26 : 184-6.
17. Falck HM, Tomroth T, Kock B, Wegeluis O. Fatal renal vasculitis and minimal change glomerulonephritis complicating treatment with Penicillamine. Acta Med Scand 1979; 205 : 133-8.
18. Fillastre JP, Druet Ph, Mery JP. Protéinuric nephropathies associated with drugs and substances of abuse. In : Cameron JS, Glassock RJ, ed 1. New York and Basel : The nephrotic syndrome. 1988; 697-744.
19. Walshe JM. Penicillamine and the SLE syndrome. J Rheumatol 1981 ; 8 (Suppl. 7) : 155-60.
20. Almirall J, Alcorta I, Botey A. Revert L. Pénicillamine-induced rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis. Am J Nephrol 1993; 13 : 286-8.
21. Banfi G, Imbasciati E, Guerra L, Mihatsch MJ, Ponticelli C. Extracapillary glomerulonephritis with necrotizing vasculitis in D-Penicillamine-treated rheumatoid arthritis. Nephron 1983; 33 : 56-60.
22. Bonan G, Caubarrere I, Beaufils H, Lucsko M. Aubert P. Hémorragie alvéolaire diffuse et glomérulonéphrite grave induites par la D-pénicillamine. Thérapie 1986; 41: 297-8.
23. Chalmers A, Thompson D, Stein HE, Reid G, Patterson AC. Systemic lupus erythematosus during Penicillamine therapy for rheumatoid arthritis. Ann Intern Med 1982; 97 : 659-63.
24. Devogelaer JP, Pirson Y, Vandenbroucke JM, Cosyns JP, Brichard S, Nagant de Deuxchaines C. D-Pénicillamine induced crescentic glomerulonephritis : Report and review of the literature. J Rheumatol 1987; 14: 1036-41.
25. Donnelly S, Levison DA, Doyle DV. Systemic lupus erythematosus-like syndrome with focal proliferative glomerulonephritis during D-Penicillamine therapy. Br J Rheumatol 1993; 32 : 251-3.
26. Gavaghan TE, McNaught PJ, Ralston M, Hayes JM. Penicillamine-induced «Goodpasture's syndrome» : Successful treatment of a fulminant case. Aust NZ J Med 1981; 11: 261-5.
27. Gibson T, Burry HC, Chisholm O. Goodpasture syndrome and D-Penicillamine. Ann intern Med 1976; 84 : 100.
28. Hasselmann M, Maurier F, Lutun P, Vetterr JM, Tempe JD. Syndrome de Goodpasture au cours d'une polyarthrite rhumatoide traitée par la D-Penicillamine. Rev Med Int 1982; 3 : 237-8.
29. Bindi P, Gilson B, Aymard B, Noel LH, Wieslander J. Antiglomerular basement membrane glomerulonephritis following D-Penicillamine associated nephrotic syndrome. Nephrol Dial Transplant 1997; 12: 325-7.
30. Macarron P, Garcia Diaz J, Azofra JA, Martin de Francisco J, Gonzalez E, Fernandez G, Sampedro J. D-Penicillamine therapy associated with rapidly progressive glomerulonephritis. Nephrol Dial Transplant 1992; 7 : 161-4.
31. Matloff DS, Kaplan MM. D-Penicillamine induced Goodpasture's like syndrome in primary biliary cirrhosis. Successful treatment with plasmapheresis and immunosuppressives. Gastroenterology 1980; 78 : 1046-9.
32. McCormick JN, Wood P, Bell D. Penicillamine induced Goodpasture's syndrome. In Munthe, Penicillamine research in rheumatic disease. Proc Symp. on Penicillamine in Rheumatic Diseases : Mode of action ; a key to pathogenesis ? Spatind, Oslo, 1976.
33. Ntoso KA, Tomaszewski JE, Jimenez SA, Neilson EG. Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis : Successful treatment of two patients and a review of the literature. Am J Kidney Dis 1986; 8 : 159-63.
34. Paces R, Riera JR, Arboleya LR, Lopez-Larrea C, Alvarez J. Goodpasture's syndrome in a patient receiving Penicillamine and Carbimazole. Nephron 1987; 45 : 316-20.
35. Sadjadi SA, Seelig MS, Berger AR, Milstoc M. Rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis during treatment with high-dosage D-Penicillamine. Am J Nephrol 1985; 5 : 212-6.
36. Sternlieb I, Bennett B, Scheinberg IH. D-Penicillamine induced Goodpasture's syndrome in Wilson's disease. Ann intern Med 1975; 82 : 673-6.
37. Swainson CP, Thomson D, Short AIK, Winney RJ. Plasma exchange in the successful treatment of drug-induced renal disease. Nephron 1982; 30 : 244-9.
38. Williams AJ, Fordham JN, Barnes CG, Goodwin FJ. Progressive proliferative glomerulonephritis in a patient with rheumatoid arthritis treated with D-Penicillamine. Ann Rheum Dis 1986; 45 : 82-4.
39. Adu D, Berisa F, Howie AJ, Emery P, Bacon PA, McConkey B, McGonigle RJS, Michaels J, Popert AJ. Glomerulonephritis in rheumatoid arthritis. Br J Rheumatol 1993; 32 : 1008-11.
40. Endo H, Hosono T, Kondo H. Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 1994; 21 : 864-70.
41. Kobayashi M, Saito M, Minoshima S, Arimura Y, Nagasawa T. A case of progressive systemic sclerosis with crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody. Nippon Jinzo Gakkai Shi 1995; 37 : 207-11.
42. Kuznetsky KA, Schwartz MM, Lohmann LA, Lewis EJ. Necrotizing glomerulonephritis in rheumatoid arthritis. Clin Nephrol 1986; 26 : 257-64.
43. Mulder AHL, Horst G, Van Leeuwen MA, Limburg PC, Kallenberg CGM. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Arthritis Rheum 1993; 8 : 1054-60.
44. Naschitz JE, Yeshurun D, Scharf Y, Sajrawi I, Lazarov NB. Boss JH. Recurrent massive alveolar hemorrhage, crescentic glomerulonephritis and necrotizing vasculitis in a patient with rheumatoid arthritis. Arch Intern Med 1989; 149 : 406-8.
45. Merkel PA, Polisson RP, Chang YL, Skates SJ, Niles JL. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 1997; 126: 866-73.
46. Hara I, Miyake H. A case of progressive systemic sclerosis complicated by crescentic glomerulonephritis and diffuse hemorrhage. Nippon Jinzi Gakkai Shi 1992; 34 : 827-33.
47. Nakano M, Karasawa R, Jokoyama Y, In H, Takayama R, Saito T, Ueno M, Ozawa T, Sato H, Nishi S, et al. Clinicopathological studies of renal disorders en patients with progressive systemic sclerosis. Nippon Jinzo Gakkai Shi 1991; 33 : 685-93.
48. Hogan SL, Nachman PH, Wilkman AS, Jennette JL, Falk RJ. Prognostic markers in patients with ANCA-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996; 7: 23-32.
49. Savage CO, Winearls CG, Evans DJ, Rees AJ, Lockwood CM. Microscopic polyarteritis : Presentation, pathology and prognosis. Q J Med 1985; 56: 467-83.
50. Bardin T, Dryll A, Debeyre N, Ryckewaert A, Legrand L, Marcelli A, Dausset TJ. HLA system and side effects of gold salts and D-Penicillamine treatment of rheumatoid arthritis. Ann Rheum Dis 1982; 41: 599-601.
51. Wooley PH, Griffin J, Panayi GS, Batchelor JR, Welsh KI, Gibson TJ. HLA-DR Antigens and toxic reaction to sodium aurothiomalate and D-Penicillamine in patients with rheumatoid arthritis. N Engl J Med 1980; 303: 300-2.
52. Moorthy AV, Zimmerman SW, Burkholder PM, Harrington AR. Association of crescentic glomerulonephritis with membranous glomerulonephropathy : A report of three cases. Clin Nephrol 1976; 6 : 319-25.
53. Nzeyimana H, Jaber W, Beaufils H, Goldstein A, Babinet F, Kernaonet E, Lebon P Proliferation extracapillaire compliquant l'évolution d'une glomérulonéphrite extramembraneuse idiopathique. Néphrologie 1995; 16 : 377-80.
54. Glassock RJ. Intensive plasma exchange in crescentic glomerulonephritis : Help or no help ? Am J Kidney Dis 1992; 20: 270-5.
55. Thompson CH, Kalowski S. Anti-glomerular basement membrane nephritis due to hydralazine. Nephron 1991 ; 58 : 238-9.
56. Leung AC, McLay A, Dobbie JW, Boulton Jones HM. Phenylbutazone-induced systemic vasculitis with crescentic glomerulonephritis. Arch Intern Med 1985; 145: 685-7.
57. Murray AN, Cassidy MJ, Templecamp C. Rapidly progressive glomerulonephritis associated with rifampicin therapy for pulmonary tuberculosis. Nephron 1987; 46: 373-6.
58. Bailey RR, Lynn KL. Crescentic glomerulonephritis developing in a patient taking enalapril. N Z Med J 1986; 99: 958-9.
59. Murray N, Lyon J, Chappell M. Crescentic glomerulonephritis : A possible complication of streptokinase treatment for myocardial infarction. Br Heart J 1986; 56: 483-5.
60. Yoshida A, Morozumi K, Takeda A, Koyama K, Oikawa T, Fujinami T. A case of rapidly progressive glomerulonephritis associated with bucillamine-treated rheumatoid arthritis. Am J Kidney Dis 1992; 20: 411-3.
61. Dolman KM, Gans ROB, Vervaat TJ, Zevenbergen G, Maingay D, Nikkels RE, Donker AJM, Von dem Borne AEG, Goldschmeding R. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993; 342 : 651-2.
62. Hor Y, Arizono K, Hara S, Kawai R, Hara M, Yamada A. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis associated with thiamizole therapy. Nephron 1996; 74: 734-5.
63. Shih DJ, Korbet SM, Rydel JJ, Schwanz MM. Renal vasculitis associated with ciprofloxacin. Am J Kidney Dis 1995; 26 : 516-9.
64. Larsson GB, Langer L, Nassberger L. Thiazide-induced kidney damage with circulating antibodies against myeloperoxidase and cardiolipin. J Intern Med 1993; 233 : 493-4.
65. Nassberger L, Sjoholm AG, Jonsson H, Sturfelt G, Akesson A. Autoantibodies against neutrophil cytoplasm components in syste-mic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol 1990; 81: 380-3.
66. Short AK, Lockwood CM. Antigen specificity in hydralazine-associated ANCA positive systemic vasculitis. Q J Med 1995; 88: 775-83.
67. Jiang X, Khursigara G, Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 1994; 266 : 810-3.
68. Jaffe IA. Adverse effects profile of sulfhydryl compounds in man. Am J Med 1986; 80 : 471-6.
69. Textor SC, Gephardt GN, Bravo EL, Tarazi RC, Fouad FM, Tubbs R, McMahon JT. Membranous glomerulopathy associated with Captopril therapy. Am J Med 1983; 74 : 705-12.
70. Jaffe IA. Penicillamine in rheumatoid arthritis : Clinical pharmacology and biochemical properties. Scand J Rheumatol 1979 ; (Suppl. 28) : 58-64.
71. Donker AJ, Venuto RC, Vladutiu AO, Brentjens JR, Andres GA. Effects of prolonged administration of D-penicillamine or captopril in various strains of rats. Brown Norway rats treated with D-pencillamine develop auto antibodies, circulating immune complexes, and disseminated intravascular coagulation. Clin Immunol immunopathol 1991 ; 30 : 145-55.
72. Goldman M, Druet P, Gleichmann E. Th2 cells in systemic autoimmunity : Insights from allogeneic diseases and chemically induced autoimmunity. Immunol Today 1991 ; 12 : 223-7.
73. Mathieson PW. Mercuric chloride-induced auto immunity. Auto immunity 1992 ; 13 : 243-7.
74. Sim E, Dodds AW, Goldin A. Inhibition of the covalent binding reaction of complement component C4 by Penicillamine, an antirheumatic agent. Biochem J 1989 ; 259 : 415-9.
75. Speerstra R, Reekers P, Van der Putte LB, Van Den Brouche JR, Rasker JJ, De Rooi DJ. HLA DR antigens and proteinuria induced by aurothioglucose and D-Penicillamine in patients with rheumatoid arthritis. J Rheumatol 1983, 10: 448-53.
76. Emery P, Panayi GS, Huston G, Welsh KI, Mitchell SC, Shah RR, Idle JR, Smith RL, Waring RH. D-Pénicillamine induced toxicity in rheumatoid arthritis. The role of sulphoxidation status and HLA DR3. J Rheumatol 1984 ; 11: 626-32.
77. Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rhumatoid arthritis. Arthritis Rheum 1990; 33 : 1665-73.